| Competition threats and rival innovation responses: Evidence from breakthrough therapies JA Garfinkel, M Hammoudeh SSRN, 2020 | 13* | 2020 |
| Governance, regulations, trade openness and FDI inflows: Empirical study MA Alshammari, MA Hammoudeh, M Pavlovic International Journal of Economics and Finance 7 (12), 44-58, 2015 | 13 | 2015 |
| Seeking efficiency or price gouging? Evidence from pharmaceutical mergers M Hammoudeh, A Nain Working Paper. SSRN, 83, 2019 | 6 | 2019 |
| Academic publishing behavior and pay across business fields JA Garfinkel, M Hammoudeh, J Weston Financial management 53 (1), 31-58, 2024 | 4 | 2024 |
| Competition and Executive Compensation: Evidence from Pharmaceutical Breakthrough Designations JA Garfinkel, M Hammoudeh, S Irlbeck, E Lie Available at SSRN, 2022 | 3* | 2022 |
| CEO Social Capital and Strategic Corporate Social Responsibility of the Firm: Bonding and Bridging Effects. M Al-Shammari, M Hammoudeh International Journal of Finance 7 (1), 1-10, 2022 | 2 | 2022 |
| The role of divestitures in horizontal mergers M Hammoudeh, A Nain, Y Qian Journal of Corporate Finance 72, 102132, 2022 | 1 | 2022 |
| Dusting Off the Old Ones: Drug Licensing to Startups, Innovation Success and Efficiency M Hammoudeh, J Krieger, J Xu Innovation Success and Efficiency (November 18, 2022), 2022 | | 2022 |
| The role of divestitures in horizontal mergers11We thank Jon Garfinkel, Jayant Kale, Kai Li, Gordon Philips, Anand Vijh, Thomas Wollmann, David Ravenscraft and participants at … M Hammoudeh, A Nain, Y Qian Journal of Corporate Finance 72 (C), 2022 | | 2022 |
| Essays in mergers and acquisitions, innovation and product markets M Hammoudeh The University of Iowa, 2021 | | 2021 |
| Governance, Regulations, Trade Openness and FDI Inflows: Empirical Study M Hammoudeh, M Al-Shammari, M Pavlovic International Journal of Economics and Finance 7 (12), 2015 | | 2015 |
